Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2008 1
2009 1
2010 1
2012 1
2013 1
2014 1
2015 3
2016 1
2017 1
2018 1
2019 1
2020 3
2021 4
2022 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Bone marrow failure syndrome 3"
Page 1
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review.
Grange L, Chalayer E, Boutboul D, Paul S, Galicier L, Gramont B, Killian M. Grange L, et al. Autoimmun Rev. 2022 Aug;21(8):103137. doi: 10.1016/j.autrev.2022.103137. Epub 2022 Jul 6. Autoimmun Rev. 2022. PMID: 35803499 Review.
BACKGROUND: Sjogren's syndrome (SjS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and lacrimal glands associated with sicca syndrome. ...Seven of them (70%) had megakaryocyte hyperplasia or reticulin fibrosis in the b …
BACKGROUND: Sjogren's syndrome (SjS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and l …
Clinical features, epidemiology, and treatment of Shwachman-Diamond syndrome: a systematic review.
Han X, Lu S, Gu C, Bian Z, Xie X, Qiao X. Han X, et al. BMC Pediatr. 2023 Oct 6;23(1):503. doi: 10.1186/s12887-023-04324-3. BMC Pediatr. 2023. PMID: 37803383 Free PMC article.
BACKGROUND: Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease which results in inherited bone marrow failure (IBMF) and is characterized by exocrine pancreatic dysfunction and diverse clinical phenotypes. ...METHODS: We searched the Wa …
BACKGROUND: Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease which results in inherited bone marrow …
Efficacy of Eltrombopag with Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone on Severe Aplastic Anaemia: A Systematic Review and Meta-analysis.
Zhang S, Wang Q, Cui K, Cheng B, Fan J, Hu S. Zhang S, et al. Clin Drug Investig. 2023 May;43(5):315-324. doi: 10.1007/s40261-023-01266-7. Epub 2023 May 11. Clin Drug Investig. 2023. PMID: 37165250 Free PMC article.
BACKGROUND AND OBJECTIVE: Severe aplastic anaemia (SAA) is a syndrome of bone marrow failure caused by T cell-mediated destruction of haematopoietic stem cells and progenitor cells. ...In terms of the primary outcomes, our pooled results indicated that …
BACKGROUND AND OBJECTIVE: Severe aplastic anaemia (SAA) is a syndrome of bone marrow failure caused by T cell-me …
A systematic review and meta-analysis of the safety and efficacy of anti-thymocyte globulin combined with eltrombopag in the treatment of severe aplastic anemia.
Zhang J, Wu Y, Liu J, Han S, Chen L, Wang H, Peng Y. Zhang J, et al. Ann Palliat Med. 2021 May;10(5):5549-5560. doi: 10.21037/apm-21-1049. Ann Palliat Med. 2021. PMID: 34107711 Free article.
The survival rate of the experimental group was higher than that of the control group, with OR =2.54, and 95% CI: 1.58 to 4.09 (Z=3.84, P=0.0001). The heterogeneity test results of the mortality rate were Chi2 =3.49, df =6, I2=0%<50%, and P=0.75>0.01. The mort …
The survival rate of the experimental group was higher than that of the control group, with OR =2.54, and 95% CI: 1.58 to 4.09 (Z=3.8 …
Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials.
Guo H, Liu C, Kang L, Liu C, Liu Y. Guo H, et al. Hematology. 2024 Dec;29(1):2335419. doi: 10.1080/16078454.2024.2335419. Epub 2024 Mar 30. Hematology. 2024. PMID: 38553907 Review.
Two reviewers performed meta-analyses using the Cochrane systematic review method and RevMan 5.3 software. RESULTS: This meta-analysis enrolled 5 studies with a total of 542 AA patients, including 274 in the experimental group and 268 in the control group. ...Eltrombopag c …
Two reviewers performed meta-analyses using the Cochrane systematic review method and RevMan 5.3 software. RESULTS: This meta-analysi …
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT).
ElGohary G, El Fakih R, de Latour R, Risitano A, Marsh J, Schrezenmeier H, Gluckman E, Höchsmann B, Pierri F, Halkes C, Alzahrani H, De la Fuente J, Cesaro S, Alahmari A, Ahmed SO, Passweg J, Dufour C, Bacigalupo A, Aljurf M. ElGohary G, et al. Bone Marrow Transplant. 2020 Oct;55(10):1906-1917. doi: 10.1038/s41409-020-0897-2. Epub 2020 Apr 28. Bone Marrow Transplant. 2020. PMID: 32346079 Review.
In total 15 studies were identified, (577 patients, 58.9% males), successful engraftment was observed in 97.3% of patients (95% CI, 95.9-98.7) while grades II-IV aGvHD and cGvHD were reported in 26.6% and 25.0%, respectively. ...
In total 15 studies were identified, (577 patients, 58.9% males), successful engraftment was observed in 97.3% of patients (95% CI, 9 …
Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
Colli A, Fraquelli M, Prati D, Casazza G. Colli A, et al. Cochrane Database Syst Rev. 2023 Jun 6;6(6):CD013532. doi: 10.1002/14651858.CD013532.pub2. Cochrane Database Syst Rev. 2023. PMID: 37278488 Free PMC article. Review.
Researchers are investigating strategies to restore liver functionality to avoid or slow progression towards end-stage liver disease. Cytokine mobilisation of stem cells from the bone marrow to the liver could improve liver function. Granulocyte colony-stimulating f …
Researchers are investigating strategies to restore liver functionality to avoid or slow progression towards end-stage liver disease. Cytoki …
Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Zhang Y, Li J, Li X, Geng Q, Xie Y, Zhang G, Wei M, Ma Y. Zhang Y, et al. Syst Rev. 2024 Apr 4;13(1):101. doi: 10.1186/s13643-024-02515-2. Syst Rev. 2024. PMID: 38576005 Free PMC article. Review.
Eltrombopag (EPAG), as a small molecule thrombopoietin receptor agonist, can stimulate the proliferation of residual HSPC and restore the bone marrow hematopoietic function of patients. In recent years, many studies have observed the efficacy and safety of IST combi …
Eltrombopag (EPAG), as a small molecule thrombopoietin receptor agonist, can stimulate the proliferation of residual HSPC and restore the …
Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
Gu Y, Estcourt LJ, Doree C, Hopewell S, Vyas P. Gu Y, et al. Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD011577. doi: 10.1002/14651858.CD011577.pub2. Cochrane Database Syst Rev. 2015. PMID: 26436602 Free PMC article. Review.
BACKGROUND: Bone marrow failure disorders include a heterogenous group of disorders, of which myelodysplastic syndrome (MDS), forms the largest subgroup. ...SELECTION CRITERIA: RCTs including patients with long-term bone marrow …
BACKGROUND: Bone marrow failure disorders include a heterogenous group of disorders, of which myelodyspla …
Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis.
Yang N, Chen J, Zhang H, Dai Z, Yao H, Ma X, Bai J, Zhang Y, Zhang W. Yang N, et al. Ann Hematol. 2017 Dec;96(12):2031-2043. doi: 10.1007/s00277-017-3136-1. Epub 2017 Sep 30. Ann Hematol. 2017. PMID: 28965225 Review.
We searched The Cochrane Library, PubMed, EMBASE, ClinicalTrials.gov , and conference proceedings of American Society of Hematology and European Society for Blood and Marrow Transplantation annual meetings. The outcomes were 3-, 6-, and 12-month response; early mort …
We searched The Cochrane Library, PubMed, EMBASE, ClinicalTrials.gov , and conference proceedings of American Society of Hematology and Euro …
31 results